Affective temperaments and personality traits in couple well-being
article
OA: diamond
CC0
Abstract
Widely recognized as the most deathful gynecologic malignancy affecting women worldwide, ovarian cancer has reported a significant decline in terms of prevalence and incidence in the last decades. This fact has been especially explained by to the use of menopausal hormonal therapy and of oral contraceptives in association with genetic, oncologic and gynecologic counseling. The aim of the current review is to discuss about actual ovarian cancer prevention and screening tools. For this reason, we reviewed several data related to ovarian cancer, such as: incidence and risk factors, histopathological types (epithelial with high- and low-grade serous carcinomas, clear cell carcinoma, mucinous carcinoma, germ cells ovarian cancer tumors), as well as screening, diagnosis and prevention methods (ovulation disruption, surgical prevention, etc.). Although progress has been reported in the last decades in terms of early diagnosis and treatment of ovarian cancer, this malignancy still represents a significant health problem affecting women worldwide. However, it seems that the golden key for optimizing the long-term outcomes in such patients is represented by a better understanding of the complex pathogenesis of this disease.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Pathogenesis and pathophysiology of endometriosis 2012
- Distinct β-Catenin and PIK3CA Mutation Profiles in Endometriosis-Associated Ovarian Endometrioid and Clear Cell Carcinomas 2015
- Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary 2014
- Management of pelvic pain caused by endometriosis 2023
References (45)
- Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary via openalex
- Distinct β-Catenin and PIK3CA Mutation Profiles in Endometriosis-Associated Ovarian Endometrioid and Clear Cell Carcinomas via openalex
- Management of pelvic pain caused by endometriosis via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- W1898717750 via openalex
- W1969144006 via openalex
- W1974592005 via openalex
- W1996568521 via openalex
- W1996737831 via openalex
- W2030404955 via openalex
- W2042241008 via openalex
- W2061926168 via openalex
- W2090287261 via openalex
- W2128996895 via openalex
- W2159134433 via openalex
- W2167610363 via openalex
- W2196212609 via openalex
- W2257957297 via openalex
- W2414821470 via openalex
- W2591245310 via openalex
- W2596634574 via openalex
- W2769025372 via openalex
- W2778311501 via openalex
- W2887583719 via openalex
- W2889646458 via openalex
- W2894340546 via openalex
- W2985192627 via openalex
- W3201437718 via openalex
- W4210480656 via openalex
- W4210962013 via openalex
- W4210987384 via openalex
- W4211022054 via openalex
- W4288739220 via openalex
- W4296474625 via openalex
- W4317436274 via openalex
- W4318484711 via openalex
- W4321094030 via openalex
- W4361295204 via openalex
- W4385063995 via openalex
- W4388765428 via openalex
- W1423334311 via openalex
- W4389203868 via openalex
- W1523215342 via openalex
- W1523496218 via openalex
- W1848424305 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK